drospirenone has been researched along with Blood Pressure, High in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (59.09) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Dožić, B; Dožić, I; Srebro, D; Vujović, S; Đogo, A | 1 |
| Cavalier, E; Dufour, P; Le Goff, C; Vroonen, L | 1 |
| Bajuk Studen, K; Jensterle Sever, M; Pfeifer, M | 1 |
| Baracat, E; Consolim-Colombo, FM; de Morais, TL; Giribela, C; Guerra, G; Mello, N; Nisenbaum, MG | 1 |
| Abreu, GR; Almeida, SA; Borgo, MV; Claudio, ER; Gouvea, SA; Graceli, JB; Moysés, MR; Podratz, PL; Romero, WG; Santos, RL; Silva, FB | 1 |
| Li, NY; Li, XL; Lin, X; Paudel, G; Wang, QY; Yu, J; Zhang, XF; Zhang, XW; Zhao, X; Zhao, Y | 1 |
| Fini, M; Gambacciani, M; Mammi, C; Rosano, GMC; Russo, N; Spoletini, I; Vitale, C; Volterrani, M | 1 |
| Preston, RA | 1 |
| Boschitsch, E; Magometschnigg, D; Mayerhofer, S | 1 |
| Arangino, S; Cagnacci, A; Ferrari, S; Napolitano, A; Piacenti, I; Volpe, A | 1 |
| Alonso, A; Karara, AH; Panzitta, D; Preston, RA; Zhang, P | 1 |
| Bakris, G; Hanes, V; Norris, PM; Pitt, B; Preston, RA; White, WB | 1 |
| Hanes, V; Pitt, B; Preston, RA; White, WB | 1 |
| He, FJ; MacGregor, GA | 1 |
| Oelkers, WH | 1 |
| Stevenson, JC | 1 |
| Chauhan, V; Hanes, V; Pitt, B; White, WB | 1 |
| Sica, DA | 1 |
| Marazzi, G; Rosano, GM; Vitale, C; Volterrani, M | 1 |
| Archer, DF | 1 |
| Hanes, V; Mallareddy, M; White, WB | 1 |
| Alonso, A; Blode, H; Hanes, V; Karara, AH; Ni, P; Poola, N; Preston, RA; Silang, R | 1 |
10 review(s) available for drospirenone and Blood Pressure, High
| Article | Year |
|---|---|
Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenes; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Coronary Artery Disease; Female; Humans; Hypertension; Incretins; Insulin Resistance; Life Style; Metformin; Middle Aged; Obesity; Polycystic Ovary Syndrome; Postmenopause; Renin-Angiotensin System; Risk Factors; Sleep Apnea, Obstructive; Thiazolidinediones; Vascular Stiffness; Weight Reduction Programs | 2013 |
Effect of combined drospirenone with estradiol for hypertensive postmenopausal women: a systemic review and meta-analysis.
Topics: Androstenes; Drug Therapy, Combination; Estradiol; Female; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Postmenopause | 2016 |
Comparative effects of conventional vs. novel hormone replacement therapy on blood pressure in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Androstenes; Antihypertensive Agents; Blood Pressure; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Postmenopause; Treatment Outcome | 2009 |
Hypertension in women: the role of progesterone and aldosterone.
Topics: Aged; Aldosterone; Androstenes; Animals; Cardiovascular Diseases; Diet, Sodium-Restricted; Estradiol; Estrogens; Female; Humans; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuresis; Progesterone; Progesterone Congeners; Renin-Angiotensin System; Risk Factors; Sex Characteristics | 2010 |
Importance of controlling blood pressure.
Topics: Androstenes; Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Diet, Sodium-Restricted; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Risk Factors; Sodium Chloride, Dietary | 2005 |
Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
Topics: Androstenes; Contraceptives, Oral; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Renin-Angiotensin System | 2005 |
A new hormone replacement therapy containing a progestogen with anti-mineralocorticoid activity.
Topics: Aged; Androstenes; Blood Pressure; Blood Pressure Determination; Edema; Female; Hormone Replacement Therapy; Humans; Hypertension; Menopause; Middle Aged; Mineralocorticoids; Progestins; Sensitivity and Specificity; Treatment Outcome; United Kingdom | 2006 |
Menopause and cardiovascular disease: the evidence.
Topics: Androstenes; Cardiovascular Diseases; Diabetes Mellitus; Estrogen Replacement Therapy; Female; Humans; Hypertension; Menopause; Mineralocorticoid Receptor Antagonists; Risk Factors; Weight Gain | 2007 |
Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current data.
Topics: Androstenes; Bone and Bones; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypertension; Menopause; Mineralocorticoid Receptor Antagonists | 2007 |
Drospirenone, a new progestogen, for postmenopausal women with hypertension.
Topics: Aged; Androstenes; Estrogen Replacement Therapy; Female; Humans; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Treatment Outcome | 2007 |
7 trial(s) available for drospirenone and Blood Pressure, High
| Article | Year |
|---|---|
Effects of a contraceptive containing drospirenone and ethinylestradiol on blood pressure, metabolic profile and neurohumoral axis in hypertensive women at reproductive age.
Topics: Adult; Aldosterone; Androstenes; Antihypertensive Agents; Baroreflex; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Electrolytes; Ethinyl Estradiol; Female; Heart Rate; Homeostasis; Humans; Hypertension; Prospective Studies; Triglycerides; Young Adult | 2014 |
Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women.
Topics: Androstenes; Blood Pressure Determination; Cardiovascular Diseases; Cells, Cultured; Double-Blind Method; Drug Combinations; Endothelial Cells; Endothelium, Vascular; Estradiol; Female; Hemodynamics; Hormone Replacement Therapy; Humans; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnenes; Postmenopause; Progestins; Pulse Wave Analysis; Reference Values; Treatment Outcome | 2017 |
Additive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril.
Topics: Aldosterone; Androstenes; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Enalapril; Estradiol; Estrogen Replacement Therapy; Female; Heart Rate; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Treatment Outcome | 2002 |
Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.
Topics: Administration, Oral; Adult; Aged; Androstenes; Blood Pressure; Drug Therapy, Combination; Estradiol; Female; Follow-Up Studies; Humans; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Osteoporosis, Postmenopausal; Potassium; Safety; Treatment Outcome | 2005 |
Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.
Topics: Aged; Aged, 80 and over; Androstenes; Antihypertensive Agents; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Homeostasis; Humans; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Office Visits; Postmenopause; Potassium; Severity of Illness Index | 2005 |
Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension.
Topics: Aged; Aldosterone; Androstenes; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cholesterol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Heart Rate; Humans; Hypertension; Middle Aged; Postmenopause; Potassium; Treatment Outcome | 2006 |
Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women.
Topics: Aged; Aldosterone; Androstenes; Antihypertensive Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Double-Blind Method; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Potassium | 2007 |
5 other study(ies) available for drospirenone and Blood Pressure, High
| Article | Year |
|---|---|
Effects of continuous-combined oral drospirenone- estradiol on blood pressure, body weight & lipid profile in early menopausal women.
Topics: Adult; Androstenes; Blood Pressure; Body Weight; Cardiovascular Diseases; Cholesterol; Estradiol; Female; Humans; Hypertension; Lipids; Menopause; Menopause, Premature; Middle Aged; Retrospective Studies | 2021 |
Inconsistencies in laboratory investigations of hypertension in a young woman taking ethinylestradiol/drospirenone association.
Topics: Adult; Aldosterone; Female; Humans; Hypertension; Renin | 2023 |
Hormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats.
Topics: Androstenes; Animals; Blotting, Western; Bradykinin; Combined Modality Therapy; Coronary Vessels; Endothelium, Vascular; Estradiol; Estrogen Receptor alpha; Estrogens; Ethidium; Female; Femoral Artery; Hemodynamics; Hormone Replacement Therapy; Hypertension; Mineralocorticoid Receptor Antagonists; Nitric Oxide Synthase Type III; Ovariectomy; Oxidative Stress; Random Allocation; Rats; Rats, Inbred SHR; Vasodilation; Vasodilator Agents | 2016 |
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study.
Topics: Adolescent; Adult; Androstenes; Blood Pressure; Cardiovascular Diseases; Circadian Rhythm; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Heart Rate; Humans; Hypertension; Young Adult | 2013 |
Drospirenone: an antihypertensive in waiting.
Topics: Age Factors; Androstenes; Antihypertensive Agents; Blood Pressure; Doping in Sports; Dose-Response Relationship, Drug; Drug Approval; Female; Humans; Hypertension; Postmenopause; United States | 2006 |